Glaukos Corp Stock Analysis

Glaukos Stock Analysis Notes

About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.64. Glaukos Corp recorded a loss per share of 2.78. The entity had not issued any dividends in recent years. Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. Glaukos Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 727 people. To learn more about Glaukos Corp call Thomas Burns at 949 367 9600 or check out https://www.glaukos.com.

Glaukos Corp Investment Alerts

Glaukos Corp Upcoming and Recent Events

Glaukos Largest EPS Surprises

View All Earnings Estimates

Glaukos Corp Thematic Classifications

Glaukos Stock Institutional Investors

Note, although Glaukos Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Glaukos Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Glaukos Corp's market, we take the total number of its shares issued and multiply it by Glaukos Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Glaukos Profitablity

The company has Profit Margin (PM) of (0.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.44) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.44.

Management Efficiency

Glaukos Corp has return on total asset (ROA) of (0.0796) % which means that it has lost $0.0796 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2716) %, meaning that it created substantial loss on money invested by shareholders. Glaukos Corp's management efficiency ratios could be used to measure how well Glaukos Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.24 in 2024. Return On Capital Employed is likely to drop to -0.16 in 2024. At this time, Glaukos Corp's Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 640 M in 2024, whereas Total Assets are likely to drop slightly above 549.7 M in 2024.

Technical Drivers

As of the 19th of April, Glaukos Corp retains the risk adjusted performance of 0.0434, and Market Risk Adjusted Performance of 0.0743. Glaukos Corp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Glaukos Corp, which can be compared to its competitors. Please check out Glaukos Corp coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Glaukos Corp is priced fairly, providing market reflects its last-minute price of 95.13 per share. Given that Glaukos Corp has jensen alpha of 0.0093, we strongly advise you to confirm Glaukos Corp's regular market performance to make sure the company can sustain itself at a future point.

Glaukos Corp Price Movement Analysis

Glaukos Corp Insider Trading Activities

Glaukos Corp Predictive Daily Indicators

Glaukos Corp Corporate Filings

Glaukos Corp Forecast Models

Glaukos Corp's time-series forecasting models are one of many Glaukos Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Glaukos Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Glaukos Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Glaukos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Glaukos Corp. By using and applying Glaukos Stock analysis, traders can create a robust methodology for identifying Glaukos entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Glaukos analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Glaukos analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Glaukos Corp stock analysis indicators help investors evaluate how Glaukos Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Glaukos Corp shares will generate the highest return on investment. By understating and applying Glaukos Corp stock analysis, traders can identify Glaukos Corp position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Glaukos Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Glaukos Stock please use our How to Invest in Glaukos Corp guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.

Is Glaukos Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Glaukos Corp. If investors know Glaukos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Glaukos Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Glaukos Corp is measured differently than its book value, which is the value of Glaukos that is recorded on the company's balance sheet. Investors also form their own opinion of Glaukos Corp's value that differs from its market value or its book value, called intrinsic value, which is Glaukos Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaukos Corp's market value can be influenced by many factors that don't directly affect Glaukos Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Glaukos Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Glaukos Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaukos Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.